Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation

Children identified with type 1 diabetes through a public health screening program tend to have a less severe form of the disease when symptoms emerge.

The Fr1da study group, based in Germany, aimed to see if diagnosing type 1 diabetes in children before they showed symptoms, and providing education and monitoring, could make the condition less severe when symptoms eventuated. Researchers compared two groups: one previously diagnosed early with screening (the Fr1da group), with one diagnosed without screening (often in DKA or ketoacidosis meaning life threateningly high blood sugar levels due to a lack of insulin production).

The screened group had better outcomes at the onset of clinical type 1 diabetes. This exhibited as lower blood sugar levels, lower doses of insulin, and fewer cases of severe diabetic ketoacidosis (DKA). An important observation was the higher fasting C-peptide concentrations and reduced need for insulin therapy in the Fr1da cases, indicating a higher beta cell reserve. 

Their findings suggests that early diagnosis, with proactive education and monitoring, can make a significant difference in how children experience the onset of type 1 diabetes.

graphical abstract

The paper is available at: https://doi.org/10.1007/s00125-023-05953-0

100 registrations!

Type1Screen registers 100 participants!

Type1Screen has registered its 100th participant via our new online portal.

The portal was launched on July 28th 2022. Our very first registrant joined August 18th 2022.

We are really pleased and thankful for the community uptake of this initiative.

If there is type 1 diabetes in your family, and you wish to get screened for your risk of the condition, you can register here.

Anyone aged 2 years or older with a family history of type 1 diabetes, and living in Australia or New Zealand, is eligible for this free screening test.

These two siblings participated in Type1Screen because their mum has Type 1 Diabetes.

Type1Screen receives DARP funding

Type1Screen receives Diabetes Australia Research (DARP) funding

We’re grateful to Diabetes Australia for a generous grant to help us bring the home testing risk screening kits over the finish line and out to families.

A. Prof John Wentworth was interviewed recently by former professional Australian rules footballer, Jack Fitzpatrick, for the Diabetes Victoria podcasts. Jack lives with type 1 diabetes himself.

The interview discussed the advancement of risk screening for type 1 diabetes and the aim to identify people in the earliest stages of the condition as possible to:

1. offer current and emerging immunotherapy trials and treatments, and

2. avoid severe illness and hospitalisation

Hear the full interview here: https://www.diabetesvic.org.au/podcasts